Peifer C - Search Results

1

Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors.

Peifer C, Urich R, Schattel V, Abadleh M, Röttig M, Kohlbacher O, Laufer S. Peifer C, et al. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1431-5. doi: 10.1016/j.bmcl.2007.12.073. Epub 2008 Jan 5. Bioorg Med Chem Lett. 2008. PMID: 18207396

2

Identification of Maleimide-Fused Carbazoles as Novel Noncanonical Bone Morphogenetic Protein Synergizers.

Riege D, Herschel S, Heintze L, Fenkl T, Wesseler F, Sievers S, Peifer C, Schade D. Riege D, et al. Among authors: peifer c. ACS Pharmacol Transl Sci. 2023 Jul 19;6(8):1207-1220. doi: 10.1021/acsptsci.3c00103. eCollection 2023 Aug 11. ACS Pharmacol Transl Sci. 2023. PMID: 37588754 Free PMC article.

3

Cell-free production of fluorescent proteins for the discovery of novel ribosome-targeting antibiotics.

Höger B, Peifer C, Beitz E. Höger B, et al. Among authors: peifer c. J Microbiol Methods. 2023 Oct;213:106814. doi: 10.1016/j.mimet.2023.106814. Epub 2023 Aug 29. J Microbiol Methods. 2023. PMID: 37652138

4

Novel Henna-Related Naphthazarine Photosensitizers for an Effective Photodynamic Therapy of Onychomycosis.

Baier J, Jansen B, Wenzel-Storjohann A, Tasdemir D, Peifer C. Baier J, et al. Among authors: peifer c. ACS Pharmacol Transl Sci. 2023 Nov 22;6(12):1958-1971. doi: 10.1021/acsptsci.3c00259. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093835 Free PMC article.

5

An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays.

Laufer S, Thuma S, Peifer C, Greim C, Herweh Y, Albrecht A, Dehner F. Laufer S, et al. Among authors: peifer c. Anal Biochem. 2005 Sep 1;344(1):135-7. doi: 10.1016/j.ab.2005.06.015. Anal Biochem. 2005. PMID: 16038870 No abstract available.

6

New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase.

Peifer C, Wagner G, Laufer S. Peifer C, et al. Curr Top Med Chem. 2006;6(2):113-49. doi: 10.2174/156802606775270323. Curr Top Med Chem. 2006. PMID: 16454763 Review.

7

Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.

Peifer C, Stoiber T, Unger E, Totzke F, Schächtele C, Marmé D, Brenk R, Klebe G, Schollmeyer D, Dannhardt G. Peifer C, et al. J Med Chem. 2006 Feb 23;49(4):1271-81. doi: 10.1021/jm0580297. J Med Chem. 2006. PMID: 16480264

8

Development and optimization of a non-radioactive JNK3 assay.

Peifer C, Luik S, Thuma S, Herweh Y, Laufer S. Peifer C, et al. Comb Chem High Throughput Screen. 2006 Sep;9(8):613-8. doi: 10.2174/138620706778249721. Comb Chem High Throughput Screen. 2006. PMID: 17017881

9

Profile and molecular modeling of 3-(indole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1 H-pyrrole-2,5-dione (1) as a highly selective VEGF-R2/3 inhibitor.

Peifer C, Krasowski A, Hämmerle N, Kohlbacher O, Dannhardt G, Totzke F, Schächtele C, Laufer S. Peifer C, et al. J Med Chem. 2006 Dec 14;49(25):7549-53. doi: 10.1021/jm0609871. J Med Chem. 2006. PMID: 17149885

10

From five- to six-membered rings: 3,4-diarylquinolinone as lead for novel p38MAP kinase inhibitors.

Peifer C, Kinkel K, Abadleh M, Schollmeyer D, Laufer S. Peifer C, et al. J Med Chem. 2007 Mar 22;50(6):1213-21. doi: 10.1021/jm061097o. Epub 2007 Feb 27. J Med Chem. 2007. PMID: 17323937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters